|
|
|
|
Incretin hormones in the treatment of type 2 diabetes
Type 2 diabetes mellitus is a progressive disease affecting more than 18 million Americans. Incretin mimetics and DPP-IV inhibitors are new classes of antihyperglycemic agents that may improve glycemic control in patients with type 2 diabetes. The incretin hormone, glucagon-like peptide 1 (GLP-1), stimulates glucose-dependent insulin secretion, suppresses inappropriate glucagon secretion, and slows gastric motility.
|
| |
More>>
|
|
|
|
|
|
History and anticipatory guidance
A structured psychosocial interview allows you to assess if, and
how, a male teenager's lifestyle or home and school environment
pose a risk to his mental and physical health. The authors show you
the right questions to ask and how to ask them—the keys to
getting your patient to open up.
|
| |
More>>
|
|
|
|
|
|
What to tell parents about low-carbohydrate dieting for children
The first article of a four-part series on nutritional interventions examines evidence on the use, safety and efficacy of low-carbohydrate dieting for weight loss and intractable epilespy.
|
| |
More>>
|
|
|
|
|
|
Evidence-based smoking cessation programs for use in primary care settings
Tobacco dependency is a growing problem among older adults. Given the addictive nature of tobacco use, smokers need a multifactorial treatment program to help stop smoking. Health care professionals can play a pivotal role in the promotion of a smoking cessation treatment program to people of all ages, including the elderly. This paper presents important evidence that smoking cessation services for the elderly are effective, and describes how primary care physicians can support elderly people quit smoking.
|
| |
More>>
|
|
|